{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T04:58:02Z","timestamp":1794891482921,"version":"4.9.1"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270262"],"award-info":[{"award-number":["82270262"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82300565"],"award-info":[{"award-number":["82300565"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Restoring cardiac function after myocardial infarction remains a major challenge, as current pharmacological and interventional therapies primarily mitigate symptoms and slow disease progression without addressing the irreversible loss of functional myocardium. Although a diverse range of biologically active agents has been developed to modulate inflammation, angiogenesis, fibrosis, and cardiomyocyte survival, their therapeutic impact is frequently limited by delivery strategies that fail to match the dynamic and heterogeneous nature of post-infarction healing. Advances in biomaterials, nanotechnology, and device engineering have enabled drug delivery systems capable of spatiotemporally programmed therapeutic engagement. By responding to injury-associated cues, recreating key features of the myocardial microenvironment, and incorporating programmable release architectures, these systems coordinate localization, release kinetics, and duration of action with distinct phases and regions of cardiac repair. When combined with appropriate delivery interfaces, including nanocarriers, injectable depots, structured platforms, and biologically derived vehicles, spatiotemporal drug delivery transforms therapy from passive administration into an active determinant of biological outcome. This Review synthesizes recent mechanistic and engineering advances to frame spatiotemporal precision as a unifying principle for cardiac drug delivery. Aligning therapeutic action with the intrinsic biology of myocardial healing provides a rational pathway toward more effective, durable, and biologically informed strategies for cardiac repair and, where biology permits, regeneration.<\/jats:p>","DOI":"10.1038\/s12276-026-01704-4","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T03:35:37Z","timestamp":1777606537000},"page":"1329-1340","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Spatiotemporal precision interventions for cardiac repair and regenerative therapy"],"prefix":"10.1038","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-1526-5173","authenticated-orcid":false,"given":"Mei Hua","family":"Ting","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huipeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1765-8445","authenticated-orcid":false,"given":"Hongjun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4746-9570","authenticated-orcid":false,"given":"Wenbin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9360-7332","authenticated-orcid":false,"given":"Junbo","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6628-3953","authenticated-orcid":false,"given":"Ning","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,1]]},"reference":[{"key":"1704_CR1","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1016\/S0140-6736(24)00367-2","volume":"403","author":"M Naghavi","year":"2024","unstructured":"Naghavi, M. et al. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet 403, 2100\u20132132 (2024).","journal-title":"Lancet"},{"key":"1704_CR2","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1002\/j.2040-4603.2015.tb00664.x","volume":"5","author":"NG Frangogiannis","year":"2015","unstructured":"Frangogiannis, N. G. Pathophysiology of myocardial infarction. Compreh Physiol 5, 1841\u20131875 (2015).","journal-title":"Compreh Physiol"},{"key":"1704_CR3","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41569-018-0036-6","volume":"15","author":"H Hashimoto","year":"2018","unstructured":"Hashimoto, H., Olson, E. N. & Bassel-Duby, R. Therapeutic approaches for cardiac regeneration and repair. Nat. Rev. Cardiol. 15, 585\u2013600 (2018).","journal-title":"Nat. Rev. Cardiol."},{"key":"1704_CR4","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.addr.2014.08.006","volume":"84","author":"CL Hastings","year":"2015","unstructured":"Hastings, C. L. et al. Drug and cell delivery for cardiac regeneration. Adv. Drug Del. Rev. 84, 85\u2013106 (2015).","journal-title":"Adv. Drug Del. Rev."},{"key":"1704_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.addr.2020.10.003","volume":"160","author":"Q Yang","year":"2020","unstructured":"Yang, Q., Fang, J., Lei, Z., Sluijter, J. P. G. & Schiffelers, R. Repairing the heart: state-of the art delivery strategies for biological therapeutics. Adv. Drug Del. Rev. 160, 1\u201318 (2020).","journal-title":"Adv. Drug Del. Rev."},{"key":"1704_CR6","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nrcardio.2014.28","volume":"11","author":"NG Frangogiannis","year":"2014","unstructured":"Frangogiannis, N. G. The inflammatory response in myocardial injury, repair, and remodelling. Nat. Rev. Cardiol. 11, 255\u2013265 (2014).","journal-title":"Nat. Rev. Cardiol."},{"key":"1704_CR7","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.jacbts.2019.02.006","volume":"4","author":"C Humeres","year":"2019","unstructured":"Humeres, C. & Frangogiannis, N. Fibroblasts in the infarcted, remodeling, and failing heart. JACC Basic Transl Sci 4, 449\u2013467 (2019).","journal-title":"JACC Basic Transl Sci"},{"key":"1704_CR8","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1172\/JCI87491","volume":"127","author":"NG Frangogiannis","year":"2017","unstructured":"Frangogiannis, N. G. The extracellular matrix in myocardial injury, repair, and remodeling. J Clin Invest 127, 1600\u20131612 (2017).","journal-title":"J Clin Invest"},{"key":"1704_CR9","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1161\/CIRCRESAHA.119.311148","volume":"125","author":"NG Frangogiannis","year":"2019","unstructured":"Frangogiannis, N. G. The extracellular matrix in ischemic and nonischemic heart failure. Circ. Res. 125, 117\u2013146 (2019).","journal-title":"Circ. Res."},{"key":"1704_CR10","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.mam.2018.07.001","volume":"65","author":"NG Frangogiannis","year":"2019","unstructured":"Frangogiannis, N. G. Cardiac fibrosis: cell biological mechanisms, molecular pathways and therapeutic opportunities. Mol. Aspects Med. 65, 70\u201399 (2019).","journal-title":"Mol. Aspects Med."},{"key":"1704_CR11","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1161\/CIRCRESAHA.115.307017","volume":"118","author":"BJ Haubner","year":"2016","unstructured":"Haubner, B. J. et al. Functional recovery of a human neonatal heart after severe myocardial infarction. Circ. Res. 118, 216\u2013221 (2016).","journal-title":"Circ. Res."},{"key":"1704_CR12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41392-020-00413-2","volume":"6","author":"R Gong","year":"2021","unstructured":"Gong, R., Jiang, Z., Zagidullin, N., Liu, T. & Cai, B. Regulation of cardiomyocyte fate plasticity: a key strategy for cardiac regeneration. Signal Transduct Target Ther. 6, 31 (2021).","journal-title":"Signal Transduct Target Ther"},{"key":"1704_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41536-025-00394-2","volume":"10","author":"A Bois","year":"2025","unstructured":"Bois, A., Grandela, C., Gallant, J., Mummery, C. & Menasch\u00e9, P. Revitalizing the heart: strategies and tools for cardiomyocyte regeneration post-myocardial infarction. npj Regen Med. 10, 6 (2025).","journal-title":"npj Regen Med"},{"key":"1704_CR14","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1161\/CIRCRESAHA.116.303577","volume":"119","author":"SD Prabhu","year":"2016","unstructured":"Prabhu, S. D. & Frangogiannis, N. G. The biological basis for cardiac repair after myocardial infarction. Circ. Res. 119, 91\u2013112 (2016).","journal-title":"Circ. Res."},{"key":"1704_CR15","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s44161-025-00739-6","volume":"4","author":"AS-F Chan","year":"2025","unstructured":"Chan, A. S.-F. et al. Spatiotemporal dynamics of the cardioimmune niche during lesion repair. Nat. Cardiovasc. Res. 4, 1550\u20131572 (2025).","journal-title":"Nat. Cardiovasc. Res."},{"key":"1704_CR16","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/s41586-022-05060-x","volume":"608","author":"C Kuppe","year":"2022","unstructured":"Kuppe, C. et al. Spatial multi-omic map of human myocardial infarction. Nature 608, 766\u2013777 (2022).","journal-title":"Nature"},{"key":"1704_CR17","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/S0140-6736(06)68074-4","volume":"367","author":"LH Opie","year":"2006","unstructured":"Opie, L. H., Commerford, P. J., Gersh, B. J. & Pfeffer, M. A. Controversies in ventricular remodelling. Lancet 367, 356\u2013367 (2006).","journal-title":"Lancet"},{"key":"1704_CR18","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/nrm3619","volume":"14","author":"M Xin","year":"2013","unstructured":"Xin, M., Olson, E. N. & Bassel-Duby, R. Mending broken hearts: cardiac development as a basis for adult heart regeneration and repair. Nat Rev Mol Cell Biol. 14, 529\u2013541 (2013).","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1704_CR19","doi-asserted-by":"crossref","unstructured":"Frangogiannis, N.G. Pathophysiology of Myocardial Infarction. Compr Physiol, 5, 1841-1875 (2015).","DOI":"10.1002\/j.2040-4603.2015.tb00664.x"},{"key":"1704_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-03047-6","volume":"22","author":"Z Gu","year":"2024","unstructured":"Gu, Z. et al. An antioxidant nanozyme for targeted cardiac fibrosis therapy post myocardial infarction. J Nanobiotechnol 22, 760 (2024).","journal-title":"J Nanobiotechnol"},{"key":"1704_CR21","doi-asserted-by":"publisher","first-page":"2308477","DOI":"10.1002\/adma.202308477","volume":"36","author":"X Liu","year":"2024","unstructured":"Liu, X. et al. A cardiac-targeted nanozyme interrupts the inflammation-free radical cycle in myocardial infarction. Adv. Mater. 36, 2308477 (2024).","journal-title":"Adv. Mater."},{"key":"1704_CR22","doi-asserted-by":"publisher","unstructured":"Zhou, J. et al. Natural melanin\/alginate hydrogels achieve cardiac repair through ROS scavenging and macrophage polarization. Adv Sci (Weinh) https:\/\/doi.org\/10.1002\/advs.202100505 (2021).","DOI":"10.1002\/advs.202100505"},{"key":"1704_CR23","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1021\/mp100253e","volume":"7","author":"W Gao","year":"2010","unstructured":"Gao, W., Chan, J. M. & Farokhzad, O. C. pH-responsive nanoparticles for drug delivery. Mol Pharm 7, 1913\u20131920 (2010).","journal-title":"Mol Pharm"},{"key":"1704_CR24","doi-asserted-by":"publisher","first-page":"7790","DOI":"10.1016\/j.biomaterials.2013.06.051","volume":"34","author":"I Somasuntharam","year":"2013","unstructured":"Somasuntharam, I. et al. Delivery of Nox2-NADPH oxidase siRNA with polyketal nanoparticles for improving cardiac function following myocardial infarction. Biomaterials 34, 7790\u20137798 (2013).","journal-title":"Biomaterials"},{"key":"1704_CR25","doi-asserted-by":"publisher","first-page":"123214","DOI":"10.1016\/j.biomaterials.2025.123214","volume":"319","author":"N Zhang","year":"2025","unstructured":"Zhang, N. et al. Biomimetic peroxisome targets myocardial injury and promotes heart repair and regeneration. Biomaterials 319, 123214 (2025).","journal-title":"Biomaterials"},{"key":"1704_CR26","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1161\/hh1501.094396","volume":"89","author":"EEJM Creemers","year":"2001","unstructured":"Creemers, E. E. J. M., Cleutjens, J. P. M., Smits, J. F. M. & Daemen, M. J. A. P. Matrix metalloproteinase inhibition after myocardial infarction. Circ. Res. 89, 201\u2013210 (2001).","journal-title":"Circ. Res."},{"key":"1704_CR27","doi-asserted-by":"publisher","first-page":"e1801217","DOI":"10.1002\/adhm.201801217","volume":"8","author":"D Bejleri","year":"2019","unstructured":"Bejleri, D. & Davis, M. E. Decellularized extracellular matrix materials for cardiac repair and regeneration. Adv Healthc Mater 8, e1801217 (2019).","journal-title":"Adv Healthc Mater"},{"key":"1704_CR28","doi-asserted-by":"publisher","first-page":"122364","DOI":"10.1016\/j.biomaterials.2023.122364","volume":"302","author":"X Wang","year":"2023","unstructured":"Wang, X. et al. Localized delivery of anti-inflammatory agents using extracellular matrix-nanostructured lipid carriers hydrogel promotes cardiac repair post-myocardial infarction. Biomaterials 302, 122364 (2023).","journal-title":"Biomaterials"},{"key":"1704_CR29","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.actbio.2019.01.062","volume":"87","author":"Z Wang","year":"2019","unstructured":"Wang, Z. et al. Decellularized neonatal cardiac extracellular matrix prevents widespread ventricular remodeling in adult mammals after myocardial infarction. Acta Biomater 87, 140\u2013151 (2019).","journal-title":"Acta Biomater"},{"key":"1704_CR30","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1021\/acs.biomac.0c00045","volume":"21","author":"J Nicolas","year":"2020","unstructured":"Nicolas, J. et al. 3D extracellular matrix mimics: fundamental concepts and role of materials chemistry to influence stem cell fate. Biomacromolecules 21, 1968\u20131994 (2020).","journal-title":"Biomacromolecules"},{"key":"1704_CR31","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.biomaterials.2015.08.045","volume":"73","author":"K Yue","year":"2015","unstructured":"Yue, K. et al. Synthesis, properties, and biomedical applications of gelatin methacryloyl (GelMA) hydrogels. Biomaterials 73, 254\u2013271 (2015).","journal-title":"Biomaterials"},{"key":"1704_CR32","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1038\/s41563-025-02234-6","volume":"24","author":"AR Sun","year":"2025","unstructured":"Sun, A. R. et al. Hybrid hydrogel\u2013extracellular matrix scaffolds identify biochemical and mechanical signatures of cardiac ageing. Nat Mater. 24, 1489\u20131501 (2025).","journal-title":"Nat Mater"},{"key":"1704_CR33","doi-asserted-by":"publisher","unstructured":"Li, J. H., Jiang, X. Q., Li, H. J., Gelinsky, M. & Gu, Z. Tailoring materials for modulation of macrophage fate. Adv. Mater. https:\/\/doi.org\/10.1002\/adma.202004172 (2021).","DOI":"10.1002\/adma.202004172"},{"key":"1704_CR34","doi-asserted-by":"publisher","first-page":"114647","DOI":"10.1016\/j.jconrel.2026.114647","volume":"391","author":"P Wang","year":"2026","unstructured":"Wang, P. et al. Dual-biomimetic nanodecoys reprogram cardiac macrophages by suppressing STING signaling for heart repair. J Control Rel 391, 114647 (2026).","journal-title":"J Control Rel"},{"key":"1704_CR35","doi-asserted-by":"publisher","first-page":"2200055","DOI":"10.1002\/adhm.202200055","volume":"11","author":"M Ghovvati","year":"2022","unstructured":"Ghovvati, M., Kharaziha, M., Ardehali, R. & Annabi, N. Recent advances in designing electroconductive biomaterials for cardiac tissue engineering. Adv Healthc Mater. 11, 2200055 (2022).","journal-title":"Adv Healthc Mater"},{"key":"1704_CR36","doi-asserted-by":"publisher","first-page":"113921","DOI":"10.1016\/j.addr.2021.113921","volume":"178","author":"GK Eleftheriadis","year":"2021","unstructured":"Eleftheriadis, G. K., Genina, N., Boetker, J. & Rantanen, J. Modular design principle based on compartmental drug delivery systems. Adv. Drug Del. Rev. 178, 113921 (2021).","journal-title":"Adv. Drug Del. Rev."},{"key":"1704_CR37","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker, P. M. et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N. Engl. J. Med. 377, 1119\u20131131 (2017).","journal-title":"N. Engl. J. Med."},{"key":"1704_CR38","doi-asserted-by":"publisher","first-page":"6862","DOI":"10.1039\/D3BM00857F","volume":"11","author":"W Lei","year":"2023","unstructured":"Lei, W. et al. Synergetic EGCG and coenzyme Q10 DSPC liposome nanoparticles protect against myocardial infarction. Biomater Sci. 11, 6862\u20136870 (2023).","journal-title":"Biomater Sci"},{"key":"1704_CR39","doi-asserted-by":"publisher","unstructured":"Carr\u00ealo, H., Soares, P. I. P., Borges, J. P. & Cidade, M. T. Injectable composite systems based on microparticles in hydrogels for bioactive cargo controlled delivery. Gels https:\/\/doi.org\/10.3390\/gels7030147 (2021).","DOI":"10.3390\/gels7030147"},{"key":"1704_CR40","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1021\/acsbiomaterials.2c01320","volume":"10","author":"B ter Mors","year":"2024","unstructured":"ter Mors, B. et al. Bioresponsive cytokine delivery responding to matrix metalloproteinases. ACS Biomater Sci Eng. 10, 29\u201337 (2024).","journal-title":"ACS Biomater Sci Eng"},{"key":"1704_CR41","doi-asserted-by":"publisher","first-page":"5421","DOI":"10.1021\/acsnano.2c10042","volume":"17","author":"X Ji","year":"2023","unstructured":"Ji, X. et al. Cysteine-based redox-responsive nanoparticles for fibroblast-targeted drug delivery in the treatment of myocardial infarction. ACS Nano 17, 5421\u20135434 (2023).","journal-title":"ACS Nano"},{"key":"1704_CR42","first-page":"5","volume":"392","author":"R Langer","year":"1998","unstructured":"Langer, R. Drug delivery and targeting. Nature 392, 5\u201310 (1998).","journal-title":"Nature"},{"key":"1704_CR43","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/s41591-021-01279-9","volume":"27","author":"S Huang","year":"2021","unstructured":"Huang, S. et al. A perfusable, multifunctional epicardial device improves cardiac function and tissue repair. Nat Med. 27, 480\u2013490 (2021).","journal-title":"Nat Med"},{"key":"1704_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50093-7","volume":"15","author":"K Su","year":"2024","unstructured":"Su, K. et al. Reformulating lipid nanoparticles for organ-targeted mRNA accumulation and translation. Nat Commun 15, 5659 (2024).","journal-title":"Nat Commun"},{"key":"1704_CR45","doi-asserted-by":"publisher","first-page":"7825","DOI":"10.1021\/acsnano.3c04507","volume":"18","author":"H Zhang","year":"2024","unstructured":"Zhang, H. et al. Fluorinated lipid nanoparticles for enhancing mRNA delivery efficiency. ACS Nano 18, 7825\u20137836 (2024).","journal-title":"ACS Nano"},{"key":"1704_CR46","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/nrd4503","volume":"14","author":"CJ Cheng","year":"2015","unstructured":"Cheng, C. J., Tietjen, G. T., Saucier-Sawyer, J. K. & Saltzman, W. M. A holistic approach to targeting disease with polymeric nanoparticles. Nat. Rev. Drug Discov. 14, 239\u2013247 (2015).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1704_CR47","doi-asserted-by":"publisher","first-page":"e0162425","DOI":"10.1371\/journal.pone.0162425","volume":"11","author":"K Ichimura","year":"2016","unstructured":"Ichimura, K. et al. A translational study of a new therapeutic approach for acute myocardial infarction: nanoparticle-mediated delivery of pitavastatin into reperfused myocardium reduces ischemia\u2013reperfusion injury in a preclinical porcine model. PLoS ONE 11, e0162425 (2016).","journal-title":"PLoS ONE"},{"key":"1704_CR48","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa2035389","volume":"384","author":"LR Baden","year":"2021","unstructured":"Baden, L. R. et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N. Engl. J. Med. 384, 403\u2013416 (2021).","journal-title":"N. Engl. J. Med."},{"key":"1704_CR49","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","volume":"15","author":"Q Cheng","year":"2020","unstructured":"Cheng, Q. et al. Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR\u2013Cas gene editing. Nat Nanotechnol 15, 313\u2013320 (2020).","journal-title":"Nat Nanotechnol"},{"key":"1704_CR50","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41586-019-1546-z","volume":"573","author":"H Aghajanian","year":"2019","unstructured":"Aghajanian, H. et al. Targeting cardiac fibrosis with engineered T cells. Nature 573, 430\u2013433 (2019).","journal-title":"Nature"},{"key":"1704_CR51","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.yjmcc.2011.02.003","volume":"50","author":"S Kanki","year":"2011","unstructured":"Kanki, S. et al. Identification of targeting peptides for ischemic myocardium by in vivo phage display. J Mol Cell Cardiol 50, 841\u2013848 (2011).","journal-title":"J Mol Cell Cardiol"},{"key":"1704_CR52","doi-asserted-by":"publisher","first-page":"3361","DOI":"10.1096\/fj.08-127373","volume":"23","author":"RC Scott","year":"2009","unstructured":"Scott, R. C. et al. Targeting VEGF-encapsulated immunoliposomes to MI heart improves vascularity and cardiac function. FASEB J 23, 3361\u20133367 (2009).","journal-title":"FASEB J"},{"key":"1704_CR53","doi-asserted-by":"publisher","first-page":"H1124","DOI":"10.1152\/ajpheart.00707.2012","volume":"304","author":"Y Yamada","year":"2013","unstructured":"Yamada, Y. et al. Postinfarct active cardiac-targeted delivery of erythropoietin by liposomes with sialyl Lewis X repairs infarcted myocardium in rabbits. Am J Physiol Heart Circ Physiol 304, H1124\u2013H1133 (2013).","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1704_CR54","doi-asserted-by":"publisher","first-page":"e2307800120","DOI":"10.1073\/pnas.2307800120","volume":"121","author":"S Chatterjee","year":"2024","unstructured":"Chatterjee, S., Kon, E., Sharma, P. & Peer, D. Endosomal escape: a bottleneck for LNP-mediated therapeutics. Proc Natl Acad Sci USA 121, e2307800120 (2024).","journal-title":"Proc Natl Acad Sci USA"},{"key":"1704_CR55","doi-asserted-by":"publisher","first-page":"e2109256118","DOI":"10.1073\/pnas.2109256118","volume":"118","author":"SA Dilliard","year":"2021","unstructured":"Dilliard, S. A., Cheng, Q. & Siegwart, D. J. On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles. Proc Natl Acad Sci USA 118, e2109256118 (2021).","journal-title":"Proc Natl Acad Sci USA"},{"key":"1704_CR56","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","volume":"99","author":"JS Suk","year":"2016","unstructured":"Suk, J. S., Xu, Q., Kim, N., Hanes, J. & Ensign, L. M. PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. Adv Drug Deliv Rev. 99, 28\u201351 (2016).","journal-title":"Adv Drug Deliv Rev"},{"key":"1704_CR57","doi-asserted-by":"crossref","unstructured":"Tan, H. et al. Platelet-like fusogenic liposome-mediated targeting delivery of miR-21 improves myocardial remodeling by reprogramming macrophages post myocardial ischemia\u2013reperfusion injury. Adv Sci (Weinh) 8, 2100787 (2021).","DOI":"10.1002\/advs.202100787"},{"key":"1704_CR58","doi-asserted-by":"publisher","first-page":"1706759","DOI":"10.1002\/adma.201706759","volume":"30","author":"RH Fang","year":"2018","unstructured":"Fang, R. H., Kroll, A. V., Gao, W. & Zhang, L. Cell membrane coating nanotechnology. Adv. Mater. 30, 1706759 (2018).","journal-title":"Adv. Mater."},{"key":"1704_CR59","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1161\/CIRCULATIONAHA.123.067097","volume":"149","author":"T Liu","year":"2024","unstructured":"Liu, T. et al. Advanced cardiac patches for the treatment of myocardial infarction. Circulation 149, 2002\u20132020 (2024).","journal-title":"Circulation"},{"key":"1704_CR60","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/nmat4590","volume":"15","author":"R Feiner","year":"2016","unstructured":"Feiner, R. et al. Engineered hybrid cardiac patches with multifunctional electronics for online monitoring and regulation of tissue function. Nat Mater 15, 679\u2013685 (2016).","journal-title":"Nat Mater"},{"key":"1704_CR61","doi-asserted-by":"publisher","unstructured":"Huang, K. et al. Immunomodulatory microneedle patch for cardiac repair in rodent and porcine models of myocardial infarction. Cell Biomater https:\/\/doi.org\/10.1016\/j.celbio.2025.100152 (2025).","DOI":"10.1016\/j.celbio.2025.100152"},{"key":"1704_CR62","doi-asserted-by":"crossref","unstructured":"Gao, Z. et al. Microneedle-mediated cell therapy. Adv Sci (Weinh) 11, 2304124 (2024).","DOI":"10.1002\/advs.202304124"},{"key":"1704_CR63","doi-asserted-by":"publisher","first-page":"2301455","DOI":"10.1002\/smtd.202301455","volume":"8","author":"H Chu","year":"2024","unstructured":"Chu, H. et al. Advances of smart stimulus-responsive microneedles in cancer treatment. Small Methods 8, 2301455 (2024).","journal-title":"Small Methods"},{"key":"1704_CR64","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1002\/adfm.201403550","volume":"25","author":"CB Rodell","year":"2015","unstructured":"Rodell, C. B. et al. Shear-thinning supramolecular hydrogels with secondary autonomous covalent crosslinking to modulate viscoelastic properties in vivo. Adv. Funct. Mater. 25, 636\u2013644 (2015).","journal-title":"Adv. Funct. Mater."},{"key":"1704_CR65","doi-asserted-by":"publisher","first-page":"42852","DOI":"10.1021\/acsami.2c08799","volume":"14","author":"A Baidya","year":"2022","unstructured":"Baidya, A. et al. A cohesive shear-thinning biomaterial for catheter-based minimally invasive therapeutics. ACS Appl Mater Interfaces 14, 42852\u201342863 (2022).","journal-title":"ACS Appl Mater Interfaces"},{"key":"1704_CR66","doi-asserted-by":"publisher","first-page":"48880","DOI":"10.1021\/acsami.4c09623","volume":"16","author":"Y Cao","year":"2024","unstructured":"Cao, Y., Fan, R., Zhu, K. & Gao, Y. Advances in functionalized hydrogels in the treatment of myocardial infarction and drug-delivery strategies. ACS Appl Mater Interfaces 16, 48880\u201348894 (2024).","journal-title":"ACS Appl Mater Interfaces"},{"key":"1704_CR67","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1093\/cvr\/cvy067","volume":"114","author":"CW Chen","year":"2018","unstructured":"Chen, C. W. et al. Sustained release of endothelial progenitor cell-derived extracellular vesicles from shear-thinning hydrogels improves angiogenesis and promotes function after myocardial infarction. Cardiovasc Res. 114, 1029\u20131040 (2018).","journal-title":"Cardiovasc Res"},{"key":"1704_CR68","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1021\/acsbiomaterials.3c01892","volume":"10","author":"VS Meli","year":"2024","unstructured":"Meli, V. S. et al. Modulation of stiffness-dependent macrophage inflammatory responses by collagen deposition. ACS Biomater Sci Eng. 10, 2212\u20132223 (2024).","journal-title":"ACS Biomater Sci Eng"},{"key":"1704_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50072-y","volume":"15","author":"S Butenko","year":"2024","unstructured":"Butenko, S. et al. Hydrogel crosslinking modulates macrophages, fibroblasts, and their communication, during wound healing. Nat Commun 15, 6820 (2024).","journal-title":"Nat Commun"},{"key":"1704_CR70","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1021\/acs.chemrev.2c00179","volume":"123","author":"P Bertsch","year":"2022","unstructured":"Bertsch, P., Diba, M., Mooney, D. & Leeuwenburgh, S. Self-healing injectable hydrogels for tissue regeneration. Chem Rev. 123, 834\u2013873 (2022).","journal-title":"Chem Rev"},{"key":"1704_CR71","first-page":"395","volume":"31","author":"M Lee","year":"2024","unstructured":"Lee, M. et al. A paintable and adhesive hydrogel cardiac patch with sustained release of ANGPTL4 for infarcted heart repair. Bioact Mater 31, 395\u2013407 (2024).","journal-title":"Bioact Mater"},{"key":"1704_CR72","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.jconrel.2024.06.015","volume":"371","author":"Z Zheng","year":"2024","unstructured":"Zheng, Z. et al. Enhancing myocardial infarction treatment through bionic hydrogel-mediated spatial combination therapy via mtDNA-STING crosstalk modulation. J Control Rel. 371, 570\u2013587 (2024).","journal-title":"J Control Rel"},{"key":"1704_CR73","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1161\/CIRCRESAHA.118.313484","volume":"123","author":"E Braunwald","year":"2018","unstructured":"Braunwald, E. Cell-based therapy in cardiac regeneration. Circ. Res. 123, 132\u2013137 (2018).","journal-title":"Circ. Res."},{"key":"1704_CR74","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/nm0405-367","volume":"11","author":"M Gnecchi","year":"2005","unstructured":"Gnecchi, M. et al. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med. 11, 367\u2013368 (2005).","journal-title":"Nat Med"},{"key":"1704_CR75","doi-asserted-by":"publisher","first-page":"120168","DOI":"10.1016\/j.biomaterials.2020.120168","volume":"255","author":"N Zhang","year":"2020","unstructured":"Zhang, N. et al. Monocyte mimics improve mesenchymal stem cell-derived extracellular vesicle homing in a mouse MI\/RI model. Biomaterials 255, 120168 (2020).","journal-title":"Biomaterials"},{"key":"1704_CR76","first-page":"201","volume":"38","author":"R Gallet","year":"2016","unstructured":"Gallet, R. et al. Exosomes secreted by cardiosphere-derived cells reduce scarring, attenuate adverse remodelling, and improve function in acute and chronic porcine myocardial infarction. Eur Heart J 38, 201\u2013211 (2016).","journal-title":"Eur Heart J"},{"key":"1704_CR77","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41551-018-0229-7","volume":"2","author":"B Liu","year":"2018","unstructured":"Liu, B. et al. Cardiac recovery via extended cell-free delivery of extracellular vesicles secreted by cardiomyocytes derived from induced pluripotent stem cells. Nat Biomed Eng. 2, 293\u2013303 (2018).","journal-title":"Nat Biomed Eng"},{"key":"1704_CR78","doi-asserted-by":"publisher","first-page":"24622","DOI":"10.1021\/acsnano.3c07878","volume":"18","author":"X Cui","year":"2024","unstructured":"Cui, X. et al. Bioderived nanoparticles for cardiac repair. ACS Nano 18, 24622\u201324649 (2024).","journal-title":"ACS Nano"},{"key":"1704_CR79","doi-asserted-by":"crossref","unstructured":"Bian, S. et al. Extracellular vesicles derived from human bone marrow mesenchymal stem cells promote angiogenesis in a rat myocardial infarction model. J Mol Med (<i>Berl) 92, 387\u2013397 (2014).","DOI":"10.1007\/s00109-013-1110-5"},{"key":"1704_CR80","doi-asserted-by":"publisher","first-page":"4150","DOI":"10.1002\/jcb.26621","volume":"119","author":"H Namazi","year":"2018","unstructured":"Namazi, H. et al. Exosomes secreted by hypoxic cardiosphere-derived cells enhance tube formation and increase pro-angiogenic miRNA. J Cell Biochem 119, 4150\u20134160 (2018).","journal-title":"J Cell Biochem"},{"key":"1704_CR81","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.ijcard.2014.12.043","volume":"182","author":"B Yu","year":"2015","unstructured":"Yu, B. et al. Exosomes secreted from GATA-4 overexpressing mesenchymal stem cells serve as a reservoir of anti-apoptotic microRNAs for cardioprotection. Int J Cardiol 182, 349\u2013360 (2015).","journal-title":"Int J Cardiol"},{"key":"1704_CR82","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.addr.2016.02.006","volume":"106","author":"P Vader","year":"2016","unstructured":"Vader, P., Mol, E. A., Pasterkamp, G. & Schiffelers, R. M. Extracellular vesicles for drug delivery. Adv. Drug Del. Rev. 106, 148\u2013156 (2016).","journal-title":"Adv. Drug Del. Rev."},{"key":"1704_CR83","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-022-01630-3","volume":"20","author":"L Mao","year":"2022","unstructured":"Mao, L. et al. Heart-targeting exosomes from human cardiosphere-derived cells improve the therapeutic effect on cardiac hypertrophy. J Nanobiotechnol 20, 435 (2022).","journal-title":"J Nanobiotechnol"},{"key":"1704_CR84","doi-asserted-by":"publisher","first-page":"12056","DOI":"10.1039\/C4NR02391A","volume":"6","author":"W Jo","year":"2014","unstructured":"Jo, W. et al. Large-scale generation of cell-derived nanovesicles. Nanoscale 6, 12056\u201312064 (2014).","journal-title":"Nanoscale"},{"key":"1704_CR85","doi-asserted-by":"crossref","unstructured":"Zhang, N. et al. Biomimetic and NOS-responsive nanomotor deeply delivery a combination of MSC-EV and mitochondrial ROS scavenger and promote heart repair and regeneration. Adv Sci (Weinh) 10, 2301440 (2023).","DOI":"10.1002\/advs.202301440"},{"key":"1704_CR86","doi-asserted-by":"publisher","first-page":"127296","DOI":"10.1016\/j.cej.2020.127296","volume":"408","author":"Y Song","year":"2021","unstructured":"Song, Y. et al. Biomimetic liposomes hybrid with platelet membranes for targeted therapy of atherosclerosis. Chem Eng J 408, 127296 (2021).","journal-title":"Chem Eng J"},{"key":"1704_CR87","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1016\/j.jacc.2023.03.393","volume":"81","author":"MM Kittleson","year":"2023","unstructured":"Kittleson, M. M. et al. 2023 ACC Expert Consensus Decision Pathway on management of heart failure with preserved ejection fraction. J Am Coll Cardiol 81, 1835\u20131878 (2023).","journal-title":"J Am Coll Cardiol"},{"key":"1704_CR88","first-page":"e895","volume":"145","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich, P. A. et al. 2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 145, e895\u2013e1032 (2022).","journal-title":"Circulation"},{"key":"1704_CR89","doi-asserted-by":"publisher","first-page":"e202421949","DOI":"10.1002\/anie.202421949","volume":"64","author":"X Wang","year":"2025","unstructured":"Wang, X. et al. Universal albumin drugs-cored spherical nucleic acid (ad-SNA) platform for targeted drug delivery. Angew. Chem. Int. Ed. 64, e202421949 (2025).","journal-title":"Angew. Chem. Int. Ed."},{"key":"1704_CR90","doi-asserted-by":"publisher","unstructured":"Mao, D. et al. Rolling-circle-amplification-based DNA-enzyme nanostructure for immobilization and functionalization of enzymes. Chem. https:\/\/doi.org\/10.1016\/j.chempr.2024.10.002 (2025).","DOI":"10.1016\/j.chempr.2024.10.002"},{"key":"1704_CR91","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/s41591-021-01659-1","volume":"28","author":"AA Voors","year":"2022","unstructured":"Voors, A. A. et al. The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial. Nat Med. 28, 568\u2013574 (2022).","journal-title":"Nat Med"},{"key":"1704_CR92","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","volume":"383","author":"M Packer","year":"2020","unstructured":"Packer, M. et al. Cardiovascular and renal outcomes with empagliflozin in heart failure. N. Engl. J. Med. 383, 1413\u20131424 (2020).","journal-title":"N. Engl. J. Med."},{"key":"1704_CR93","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1080\/13543784.2023.2196010","volume":"32","author":"A Dihoum","year":"2023","unstructured":"Dihoum, A., Rena, G., Pearson, E. R., Lang, C. C. & Mordi, I. R. Metformin: evidence from preclinical and clinical studies for potential novel applications in cardiovascular disease. Exp Opin Investig Drugs 32, 291\u2013299 (2023).","journal-title":"Exp Opin Investig Drugs"},{"key":"1704_CR94","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1161\/CIRCULATIONAHA.121.056171","volume":"145","author":"SG Deftereos","year":"2022","unstructured":"Deftereos, S. G. et al. Colchicine in cardiovascular disease: in-depth review. Circulation 145, 61\u201378 (2022).","journal-title":"Circulation"},{"key":"1704_CR95","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1161\/CIRCRESAHA.116.308537","volume":"120","author":"A Oesterle","year":"2017","unstructured":"Oesterle, A., Laufs, U. & Liao, J. K. Pleiotropic effects of statins on the cardiovascular system. Circ. Res. 120, 229\u2013243 (2017).","journal-title":"Circ. Res."},{"key":"1704_CR96","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/s41586-023-06585-5","volume":"622","author":"X Li","year":"2023","unstructured":"Li, X. et al. Inhibition of fatty acid oxidation enables heart regeneration in adult mice. Nature 622, 619\u2013626 (2023).","journal-title":"Nature"},{"key":"1704_CR97","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/s44161-024-00531-y","volume":"3","author":"Y Shi","year":"2024","unstructured":"Shi, Y. et al. \u03b1-Ketoglutarate promotes cardiomyocyte proliferation and heart regeneration after myocardial infarction. Nat Cardiovasc Res. 3, 1083\u20131097 (2024).","journal-title":"Nat Cardiovasc Res"},{"key":"1704_CR98","doi-asserted-by":"publisher","first-page":"13805","DOI":"10.1021\/jacs.3c14247","volume":"146","author":"Y Huang","year":"2024","unstructured":"Huang, Y. et al. Enzyme core spherical nucleic acid that enables enhanced cuproptosis and antitumor immune response through alleviating tumor hypoxia. J Am Chem Soc. 146, 13805\u201313816 (2024).","journal-title":"J Am Chem Soc"},{"key":"1704_CR99","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1161\/CIRCULATIONAHA.124.072733","volume":"152","author":"GG Bann","year":"2025","unstructured":"Bann, G. G. et al. Cellular reprogramming by PHF7 enhances cardiac function following myocardial infarction. Circulation 152, 616\u2013629 (2025).","journal-title":"Circulation"},{"key":"1704_CR100","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.stem.2019.03.022","volume":"25","author":"H Hashimoto","year":"2019","unstructured":"Hashimoto, H. et al. Cardiac reprogramming factors synergistically activate genome-wide cardiogenic stage-specific enhancers. Cell Stem Cell 25, 69\u201386.e65 (2019).","journal-title":"Cell Stem Cell"},{"key":"1704_CR101","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1161\/CIRCRESAHA.116.308741","volume":"120","author":"S Dal-Pra","year":"2017","unstructured":"Dal-Pra, S., Hodgkinson, C. P., Mirotsou, M., Kirste, I. & Dzau, V. J. Demethylation of H3K27 is essential for the induction of direct cardiac reprogramming by miR combo. Circ Res. 120, 1403\u20131413 (2017).","journal-title":"Circ Res"},{"key":"1704_CR102","doi-asserted-by":"publisher","first-page":"9946","DOI":"10.1021\/acsomega.3c06571","volume":"9","author":"Z Gerdan","year":"2024","unstructured":"Gerdan, Z., Saylan, Y. & Denizli, A. Biosensing platforms for cardiac biomarker detection. ACS Omega 9, 9946\u20139960 (2024).","journal-title":"ACS Omega"},{"key":"1704_CR103","doi-asserted-by":"publisher","unstructured":"Xiang, Z. et al. Bioactive fibrous scaffolds with programmable release of polypeptides regulate inflammation and extracellular matrix remodeling. Regen Biomater https:\/\/doi.org\/10.1093\/rb\/rbad010 (2023).","DOI":"10.1093\/rb\/rbad010"},{"key":"1704_CR104","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1038\/s41563-024-01867-3","volume":"23","author":"B Li","year":"2024","unstructured":"Li, B. et al. Accelerating ionizable lipid discovery for mRNA delivery using machine learning and combinatorial chemistry. Nat Mater 23, 1002\u20131008 (2024).","journal-title":"Nat Mater"},{"key":"1704_CR105","doi-asserted-by":"publisher","unstructured":"Witten, J. et al. Artificial intelligence-guided design of lipid nanoparticles for pulmonary gene therapy. Nat Biotechnol https:\/\/doi.org\/10.1038\/s41587-024-02490-y (2024).","DOI":"10.1038\/s41587-024-02490-y"}],"container-title":["Experimental &amp; Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01704-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01704-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01704-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T04:39:10Z","timestamp":1780547950000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01704-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":105,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["1704"],"URL":"https:\/\/doi.org\/10.1038\/s12276-026-01704-4","relation":{},"ISSN":["2092-6413"],"issn-type":[{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,1]]},"assertion":[{"value":"23 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}